RheumNow

RT @Gibson_RheumPAC Important rheumatology signal: dupilumab-associated inflammatory arthritis. Usually seronegative, i https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 02/13/2026 – 18:30 RheumNow Dr. John […]

RT @@Gibson_RheumPAC Eczematous eruptions with IL-17 inhibition are increasingly recognized. Registry data suggest hig https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 02/13/2026 – 17:00

Maui Potpourri (2.13.2026) jjcush@gmail.com Fri, 02/13/2026 – 16:35

Most inhibition of inflammation is via the brain. More GLP1 and GIP1 receptors are in the brain, more than the

Incretins/GLP-1s are being investigated widely. @RWCSmtg #RWCS26 https://t.co/57JzRJfK8l https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 02/13/2026 – 16:26 RheumNow Dr. John Cush Incretins/GLP-1s are

Dr. Willa Tsueh taking on hx of GLP-1 agonists. The first ones, Victoza and Tulicity go back to 2010. @RWCSmtg

The hx and timeline of GLP1a development. @RWCSmtg #RWCS26 https://t.co/7tPgcRy4Ze https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 02/13/2026 – 16:18 RheumNow Dr. John Cush

#RNL26 Haque @HopkinsRheum 1/2 of Americans will be obese by 2030 “Obesity is common & obesity is expensive” Ad https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg

RT @ericdeinMD #RNL26 Dx Modification of OA @Tuhina_Neogi Challenge in drug develop: Models in young animal, not like h https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg

RT @ericdeinMD #RNL26 Placebo in Rheumatology – STEP talk Kerschbaumer What plays role in PBO? Treatment adherence effe https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

RT @richardPAconway Who to screen for RA-ILD is a tricky one. It is not feasible to screen everyone. This is

RT @richardPAconway Disease activity is a strong risk factor for RA-ILD. Particularly for moderate/high disease activity https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 02/13/2026

RNL 26 Report: RA-ILD Audrey Gibson, PA-C, reports from RheumNow Live 2026 in Dallas, Texas, on the lecture, “ILD in

Vasculitis Sunday’s vasculitis session at RNL26 was a fantastic update on inflamed blood vessels, large and small, b https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

RT @richardPAconway Lifetime risk of ILD by RA/sex/MUC5B status. We can see the synergistic effect. Also note RA&g https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…

RT @richardPAconway MUC5B is strong risk factor for RA-ILD. Specifically for UIP. Associated with both older-onset RA, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,

RT @ericdeinmd RA-ILD #RNL26 Jeff Sparks MTX and ILD – Rare MTX-induced pneumonitis. 7 cases in n=4786 (0.3% cases) vs

RT @ericdeinmd #RNL26 RA-ILD Jeff Sparks ILD pooled prevalence 0.11 Sparks: “prevalence is high but not so high that we

RT @Gibson_RheumPAC GLP-1 receptor agonists do more than promote weight loss. They impact insulin resistance, inflamma https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 02/12/2026

RT @Gibson_RheumPAC Obesity doesn’t just increase risk of rheumatic diseases-it worsens outcomes. Patients with obes https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 02/12/2026 –

BREAKING NEWS: How many patients with RA achieve and maintain remission with a JAKi? Find out in the RheumNow poster

We are Doctors, Not Providers! With apologies to Shakespeare, names are important. In health care, they can have ethic https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg

Staying Ahead of Spondyloarthritis The diagnosis and treatment of spondyloarthritis can present challenging clinical s https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 02/12/2026 –

APPs: Controversies and Misconceptions https://t.co/tO4O6OaQxi https://t.co/ThvfqiWLe3 https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 02/12/2026 – 09:01 RheumNow Dr. John Cush APPs: Controversies and Misconceptions

Obesity, Surgery, and Optimizing Patient Care ejdein@gmail.com Thu, 02/12/2026 – 08:00